| Morgan John Schiermeier, MD | |
|
180 Northstar Dr, Holts Summit, MO 65043-1123 | |
| (573) 896-5115 | |
| (573) 896-4272 |
| Full Name | Morgan John Schiermeier |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 180 Northstar Dr, Holts Summit, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841552700 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2012016520 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Capital Region Medical Center | Jefferson city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Curators Of The University Of Missouri | 4486759560 | 959 |
| Capital Region Medical Center | 4688573686 | 168 |
News Archive
Even as a girl, Dr. Kate Dewar seemed destined to inherit the small-town medical practice of her grandfather and father. ... But when she finishes residency this summer, Dr. Dewar, 31, will not be going home. Instead, she will take a job as a salaried emergency room doctor at a hospital in Elmira, N.Y., two hours away.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
CureDiva is proud to announce the official launch of the first ever, one-of-a-kind, high-end shopping and community platform that provides women with breast cancer, at every treatment phase, with all of their lifestyle needs.
Income, not just race, explains much of the health gap between groups of Americans, and a "health equity impact" statement should accompany government policy proposals, suggests a Harvard professor in the current edition of the prestigious journal Health Affairs.
› Verified 6 days ago
| Entity Name | Community Health Ctr Of Central Missouri |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538213244 PECOS PAC ID: 2062456015 Enrollment ID: O20050610000717 |
News Archive
Even as a girl, Dr. Kate Dewar seemed destined to inherit the small-town medical practice of her grandfather and father. ... But when she finishes residency this summer, Dr. Dewar, 31, will not be going home. Instead, she will take a job as a salaried emergency room doctor at a hospital in Elmira, N.Y., two hours away.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
CureDiva is proud to announce the official launch of the first ever, one-of-a-kind, high-end shopping and community platform that provides women with breast cancer, at every treatment phase, with all of their lifestyle needs.
Income, not just race, explains much of the health gap between groups of Americans, and a "health equity impact" statement should accompany government policy proposals, suggests a Harvard professor in the current edition of the prestigious journal Health Affairs.
› Verified 6 days ago
| Entity Name | Capital Region Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477980837 PECOS PAC ID: 4688573686 Enrollment ID: O20070323000507 |
News Archive
Even as a girl, Dr. Kate Dewar seemed destined to inherit the small-town medical practice of her grandfather and father. ... But when she finishes residency this summer, Dr. Dewar, 31, will not be going home. Instead, she will take a job as a salaried emergency room doctor at a hospital in Elmira, N.Y., two hours away.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
CureDiva is proud to announce the official launch of the first ever, one-of-a-kind, high-end shopping and community platform that provides women with breast cancer, at every treatment phase, with all of their lifestyle needs.
Income, not just race, explains much of the health gap between groups of Americans, and a "health equity impact" statement should accompany government policy proposals, suggests a Harvard professor in the current edition of the prestigious journal Health Affairs.
› Verified 6 days ago
| Entity Name | The Curators Of The University Of Missouri |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235126921 PECOS PAC ID: 4486759560 Enrollment ID: O20070418000290 |
News Archive
Even as a girl, Dr. Kate Dewar seemed destined to inherit the small-town medical practice of her grandfather and father. ... But when she finishes residency this summer, Dr. Dewar, 31, will not be going home. Instead, she will take a job as a salaried emergency room doctor at a hospital in Elmira, N.Y., two hours away.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
CureDiva is proud to announce the official launch of the first ever, one-of-a-kind, high-end shopping and community platform that provides women with breast cancer, at every treatment phase, with all of their lifestyle needs.
Income, not just race, explains much of the health gap between groups of Americans, and a "health equity impact" statement should accompany government policy proposals, suggests a Harvard professor in the current edition of the prestigious journal Health Affairs.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Morgan John Schiermeier, MD 180 Northstar Dr, Holts Summit, MO 65043-1123 Ph: (573) 896-5115 | Morgan John Schiermeier, MD 180 Northstar Dr, Holts Summit, MO 65043-1123 Ph: (573) 896-5115 |
News Archive
Even as a girl, Dr. Kate Dewar seemed destined to inherit the small-town medical practice of her grandfather and father. ... But when she finishes residency this summer, Dr. Dewar, 31, will not be going home. Instead, she will take a job as a salaried emergency room doctor at a hospital in Elmira, N.Y., two hours away.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
CureDiva is proud to announce the official launch of the first ever, one-of-a-kind, high-end shopping and community platform that provides women with breast cancer, at every treatment phase, with all of their lifestyle needs.
Income, not just race, explains much of the health gap between groups of Americans, and a "health equity impact" statement should accompany government policy proposals, suggests a Harvard professor in the current edition of the prestigious journal Health Affairs.
› Verified 6 days ago
Dr. Curtis W Dyer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 140 Northstar Dr, Holts Summit, MO 65043 Phone: 573-896-8301 Fax: 573-896-8589 |